Apple Turns 50: From Garage Startup to AI Crossroads 
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
IRVING, Texas, Oct. 12, 2016 -- HMS Holdings Corp. (NASDAQ:HMSY) today announced that Alex Michael Azar II has been appointed to the HMS Board of Directors, effective October 11, 2016. Mr. Azar is President, Lilly USA, LLC, the largest affiliate of Eli Lilly & Company (NYSE:LLY). Prior to joining Lilly, Mr. Azar was the Deputy Secretary (2005-2007) and General Counsel (2001-2005) at the U.S. Department of Health & Human Services.
“Alex Azar brings an important blend of government and industry experience to our Board,” said Bill Lucia, Chairman and CEO. “He has an informed perspective on healthcare policy which will enrich our Board dialogue. In addition, Alex has extensive experience with big data in his current role at Lilly which is particularly relevant as we expand into the care management and data analytics field with our recent acquisition of Essette.”
Prior to his service at HHS, Mr. Azar was in private legal practice. He is a graduate of Dartmouth College and the Yale Law School, and was a Law Clerk to U.S. Supreme Court Justice Antonin Scalia.
“Expenditures in government programs - whether administered by CMS, state governments or health plans – are projected to continue growing at an unsustainable level. I look forward to joining the HMS Board and utilizing my public and private healthcare experience to contribute to its strategic discussion about ongoing efforts by HMS to develop and acquire solutions for payers that help bend the cost curve,” commented Mr. Azar.
About HMS
HMS Holdings Corp., through its subsidiaries, provides coordination of benefits, payment integrity and care management solutions for payers. The Company serves state Medicaid programs; health plans, including Medicaid managed care, Medicare Advantage and group and individual health lines of business; federal government health agencies, including the Centers for Medicare & Medicaid Services and the Veterans Health Administration; government and private employers; and other healthcare payers and sponsors, including child support agencies. As a result of the Company’s services, customers recover billions of dollars annually and save billions more through the prevention of improper payments.
Investor Contact: Dennis Oakes SVP, Investor Relations [email protected] 212-857-5786 Media Contact: Francesca Marraro VP, Marketing and Communications [email protected] 212-857-5442
